Amelioration of experimental autoimmune encephalomyelitis by β-elemene treatment is associated with Th17 and Treg cell balance.
Experimental autoimmune encephalomyelitis (EAE), an animal mode of multiple sclerosis (MS), was previously considered that is mediated by Th1 cells. However, a number of recent studies provided strong evidence that T helper cells that produce interleukin (IL)-17 (Th17) and anti-inflammatory CD4+ Foxp3+ regulatory T cells (Tregs) play a dominant role in the pathogenesis of EAE. β-elemene is a natural antitumor plant drug with the role of multiple target, and it has been found to pass through the blood-brain barrier easily. It also has been strongly implicated as an immune modulatory agent, but the precise mechanisms of its action are largely unknown. In the present study, we mainly investigated the efficacy and mechanism of β-elemene against EAE in vivo and vitro. The treatment of C57 mice with β-elemene significantly delayed the onset of EAE, markedly suppressed MOG-specific T cell proliferation in a dose-dependent manner, dramatically reduced the IL-17, IL-6, IL-23, and RORγt production and induced the Foxp3 expression in both the periphery and the inflamed spinal cord. These findings indicated that β-elemene amelioration EAE was, to a large extent, due to inhibit differentiation and development of Th17 cells depends on down-regulating expression of IL-6, IL-23, RORγt signaling, and promoting expansion in Treg cells. Suggesting it is useful in the control of MS and other Th17 cell-mediated inflammatory diseases.
Department of Geriatrics, The First Affiliated Hospital of China Medical University, No.155 Nanjing Bei Street, Heping, 110001 Shenyang, Liaoning, People's Republic of China.
Rongwei
R
Zhang
Ayong
A
Tian
Huimin
H
Zhang
Zhike
Z
Zhou
Hongmei
H
Yu
Lei
L
Chen
D000818:Animals; D049109:Cell Proliferation; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000139:chemically induced / Q000188:drug therapy* / Q000276:immunology* / Q000473:pathology; D005260:Female; D006023:Glycoproteins / Q000276:immunology; D006801:Humans; D051379:Mice; D008810:Mice, Inbred C57BL; D009103:Multiple Sclerosis / Q000276:immunology; D063308:Myelin-Oligodendrocyte Glycoprotein; D010446:Peptide Fragments / Q000276:immunology; D012717:Sesquiterpenes / Q000627:therapeutic use*; D050378:T-Lymphocytes, Regulatory / Q000276:immunology* / Q000502:physiology; D058504:Th17 Cells / Q000276:immunology* / Q000502:physiology
D006023:Glycoproteins; D063308:Myelin-Oligodendrocyte Glycoprotein; D010446:Peptide Fragments; D012717:Sesquiterpenes; C445979:beta-elemene; C445081:myelin oligodendrocyte glycoprotein (35-55)
J Immunol. 2002 Nov 1;169(9):4712-6
12391178
Immunity. 2008 Jul 18;29(1):44-56
18585065
J Biol Chem. 2008 Jun 20;283(25):17003-8
18434325
Nature. 2008 Jul 17;454(7202):350-2
18469800
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2000 Sep;20(9):645-8
11789165
J Exp Med. 2004 Apr 5;199(7):971-9
15067033
Nat Immunol. 2006 Jun;7(6):539-41
16715060
Cell Immunol. 2005 Oct;237(2):123-30
16386239
J Immunol. 2008 Apr 15;180(8):5167-71
18390697
Annu Rev Immunol. 1999;17:701-38
10358772
Eur J Immunol. 2006 Feb;36(2):318-26
16402407
Nature. 2006 May 11;441(7090):235-8
16648838
J Exp Med. 2001 Sep 3;194(5):669-76
11535634
Am J Pathol. 2008 Jan;172(1):146-55
18156204
J Immunol. 2005 Sep 1;175(5):3025-32
16116190
Nat Immunol. 2005 Apr;6(4):345-52
15785760
J Exp Med. 2005 Jan 17;201(2):233-40
15657292
Nat Immunol. 2007 Sep;8(9):967-74
17581537
J Exp Med. 2007 Jan 22;204(1):41-7
17227914
Nat Immunol. 2003 Apr;4(4):330-6
12612578
J Immunol. 2007 Feb 1;178(3):1372-8
17237384
Zhonghua Zhong Liu Za Zhi. 1999 Nov;21(6):405-8
11776611
Zhonghua Zhong Liu Za Zhi. 1996 Nov;18(6):464-7
9387305
Nat Immunol. 2008 Jun;9(6):641-9
18454151
Curr Drug Targets Inflamm Allergy. 2005 Apr;4(2):239-45
15853746
Annu Rev Immunol. 1998;16:495-521
9597139
Immunity. 2008 Jan;28(1):29-39
18164222
Nature. 2006 May 11;441(7090):231-4
16648837
Ai Zheng. 2003 Sep;22(9):959-63
12969529
J Exp Med. 2001 Sep 3;194(5):F27-30
11535639
Ann N Y Acad Sci. 2007 Apr;1103:11-8
17376825
J Immunol. 2006 Jul 1;177(1):566-73
16785554
Annu Rev Immunol. 1989;7:145-73
2523712
Proc Natl Acad Sci U S A. 2004 Oct 26;101(43):15434-9
15492218
Zhong Yao Tong Bao. 1984 Mar;9(2):83-7
6235951
J Exp Med. 2003 Dec 15;198(12):1875-86
14676299
Nature. 2008 May 8;453(7192):236-40
18368049
Curr Opin Immunol. 2007 Jun;19(3):281-6
17433650
J Biol Chem. 2007 Nov 30;282(48):34605-10
17884812
Zhonghua Zhong Liu Za Zhi. 2001 May;23(3):196-8
11783084
J Immunol. 2005 Nov 1;175(9):5591-5
16237044
J Immunol. 2008 May 1;180(9):6070-6
18424728
Nature. 2007 Jul 26;448(7152):480-3
17581589
Cell. 2006 Sep 22;126(6):1121-33
16990136